Market Overview

Pancreatic Fistula Treatment Market is Expected to Grow at the CAGR of 5.7% During 2018-2026: Credence Research

Share:

SAN JOSE, Calif., Aug. 20, 2018 (GLOBE NEWSWIRE) -- The latest market report published by Credence Research, Inc. "Pancreatic Fistula Treatment Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026," the global pancreatic fistula treatment market was valued at US$ 1,708.6 Mn in 2017 expanding at a CAGR of 5.7% from 2018 to 2026.

Market Insights

Postoperative pancreatic fistula (POPF) is identified as one of the major medical complications and is a potentially chronic, life-threatening incident which prolongs the hospital stay and increases healthcare costs. A research study published by Mosby suggested that, after pancreaticoduodenectomy the reported rate of POPF is highly variable, ranging from 2% to more than 20%, this disparity is based on prevalence of pancreatic cancer and population density of each country or region. There are three types of pancreatic fistulas such as high output fistula, mixed fistula, and end fistula. In case of high fistula, fluid output is greater than 200 mL in 24 hours; mixed fistulas drain pancreatic fluid along with enteric contents, and in end fistula pancreatic duct disrupts in shape. Thus, usually POPF is managed with methods such as pancreatic duct ligation, pancreatic duct obliteration, pancreaticojejunostomy, and pancreaticogastrostomy. In different treatment regimens comprise control of sepsis, maintenance of fluid & electrolyte balance, somatostatin analogue, percutaneous treatment, and surgery.

In terms of treatment, the pancreatic fistula treatment is categorized into drugs and surgical devices. The drugs segment is further classified into octreotide and total parenteral nutrition (TPN). The surgical devices segment is expected to dominate the market during the forecast period owing to comparatively higher adoption of medical devices to diagnose and treat pancreatic fistula. Increasing launches of generic drugs & pipeline of octreotide drugs in clinical trials are expected to support the market growth in the near future. Total parenteral nutrition segment dominated the drugs market in 2017 attributed to augmented demand for parenteral nutrition products including single dose amino acid solution, carbohydrates, parenteral lipid emulsion, trace elements, vitamins, and minerals as it suppresses production of pancreatic enzymes by restricting the oral intake of food and maintains the nutrition of the patient. In addition, extensive use of sphincterotome, biliary & pancreatic stents, guidewires, balloons, and cannulae while performing ERCP to manage pancreatic fistula is supporting the dominance of the surgical devices segment.

North America accounted for the largest share in global pancreatic fistula treatment market, due to key driving factors such as rising prevalence of pancreatic cancer and pancreatic neuroendocrine tumors. Moreover, rising awareness regarding the post-operative complications of pancreaticoduodectomy, pancreaticojejunostomy, pancreatectomy among the medical practitioners expected to boost market growth.  Asia Pacific is anticipated to exhibit rapid growth owing to growing geriatric population susceptible to pancreatic cancer, adenocarcinoma, pancreatic neuroendocrine tumors and other gastrointestinal and lifestyle diseases. Growing healthcare infrastructure for efficient and preventive pancreatic surgeries will increase the demand for endoscopic retrograde cholangiopancreatography (ERCP) devices for the management of pre and post-operative complications related to pancreatic surgeries.  The prominent players actively engaged in the pancreatic fistula treatment market are Cook Medical, Inc., CONMED Corporation, Fresenius Kabi AG, B. Braun Melsungen Ag, Becton Dickinson & Company, Medtronic plc, Novartis AG and Others.

Key Market Movements:

  • Rising prevalence of pancreatic cancer and neuroendocrine tumors worldwide
  • Growing cases of post-operative pancreatic fistula to drive the growth of pancreatic fistula treatment market
  • Organized guidelines for the treatment of pancreatic fistula

Browse Full Report With TOC, Figures And Tables @ https://www.credenceresearch.com/report/pancreatic-fistula-treatment-market

Related Reports:

Drug Delivery Technologies Market

ECG Equipment Market

Infusion Pumps Market

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact:

Name: Chris Smith

Designation: Global Sales Manager

E-mail: sales@credenceresearch.com 

Ph: +1-800-361-8290

Connect With US:

Web:  Credence Research

Facebook @ https://www.facebook.com/CredenceResearch

Twitter @ https://twitter.com/CredenceResearc

Linkedin @ https://us.linkedin.com/company/credenceresearch

G+ @ https://plus.google.com/+Credenceresearch

Our Blog: http://www.mobilecomputingtoday.co.uk/8041/pancreatic-fistula-treatment-market-expected-exhibit-steady-growth-rate-forecast-period-credence-research/

Primary Logo

View Comments and Join the Discussion!
 

Latest Ratings

StockFirmActionPT
NKEOppenheimerUpgrades0.0
SBEvercore ISI GroupUpgrades4.5
PTIRBC CapitalUpgrades0.0
GPSJP MorganDowngrades24.0
GIIIB. Riley FBRUpgrades47.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.